Free · No account

Create your own personal news briefing

A daily PDF of the news that moves your tickers — summaries and market impact, delivered an hour before the open.

Back to The Tape

PRNewsWire

06 Aug 2026, 22:51 UTC · 1h ago

PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit

NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

ShareX LinkedIn

PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit

What the story claims

3 claims · each scored for market impact

What matters in this story

1
PROCEPT BioRobotics is facing a securities fraud class action lawsuit alleging that it artificially inflated revenues and sales through an undisclosed discount program. — Allegations of revenue manipulation and fraudulent financial reporting are severe catalysts that typically trigger significant stock price declines and loss of investor trust.
-0.80
2
The lawsuit claims PROCEPT created a field inventory glut of over 10,000 excess handpiece units by incentivizing bulk orders that exceeded actual procedure demand. — A significant inventory overhang suggests future revenue will be depressed as customers draw down existing stock rather than placing new orders.
-0.60
3
The company allegedly failed to achieve its stated 2025 handpiece sales and revenue guidance due to the unsustainable nature of its sales practices. — Missing financial guidance indicates a deterioration in fundamental business performance and suggests a need for downward valuation revisions.
-0.50

6 related stories

PRNewsWire
2h ago
ADMA Biologics, Inc. Deadline: ADMA Investors with Losses in Excess of $100K Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
- biotech
- class action
- lawsuit
Read

PRCT Investors Have Oppor… — PRCT -1.00 | NewsImpactScreener

PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit

What matters in this story

ADMA Biologics, Inc. Deadline: ADMA Investors with Losses in Excess of $100K Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm

PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit

What matters in this story

ADMA Biologics, Inc. Deadline: ADMA Investors with Losses in Excess of $100K Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm

How each ticker is affected

Track these names every morning.

Impact by category

Biggest drivers

Most positively impacted

Most negatively impacted

PNR INVESTOR DEADLINE: Pentair plc Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit

CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit

WIX INVESTOR ALERT: Wix.com Ltd. Investors with Substantial Losses Have Opportunity to Lead the Wix Class Action Lawsuit

REGN INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit

ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR

PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit

What matters in this story

Next reads from the same story arc

ADMA Biologics, Inc. Deadline: ADMA Investors with Losses in Excess of $100K Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm

PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit

What matters in this story

Next reads from the same story arc

ADMA Biologics, Inc. Deadline: ADMA Investors with Losses in Excess of $100K Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm

How each ticker is affected

Track these names every morning.

Impact by category

Biggest drivers

Most positively impacted

Most negatively impacted

PNR INVESTOR DEADLINE: Pentair plc Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit

CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit

WIX INVESTOR ALERT: Wix.com Ltd. Investors with Substantial Losses Have Opportunity to Lead the Wix Class Action Lawsuit

REGN INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit

ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR